2022
DOI: 10.3390/biology11040615
|View full text |Cite
|
Sign up to set email alerts
|

Transvenous Lead Extraction in Patients with Cardiac Implantable Device: The Impact of Systemic and Local Infection on Clinical Outcomes—An ESC-EHRA ELECTRa (European Lead Extraction Controlled) Registry Substudy

Abstract: Background: Infections of cardiac implantable devices (CIEDI) have poor outcomes despite improvement in lead extraction (TLE) procedures. Methods: To explore the influence of CIEDI on the outcomes of TLE and the differences between patients with systemic (Sy) vs. local (Lo) CIEDI, we performed a sub-analysis of the EORP ELECTRa (European Lead Extraction ConTRolled) Registry. Results: Among 3555 patients enrolled by 73 centers in 19 Countries, the indication for TLE was CIEDI in 1850: 1170 with Lo-CIEDI and 680… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(6 citation statements)
references
References 28 publications
0
6
0
Order By: Relevance
“…A considerable number of reports have been published on long-term survival following transvenous lead extraction [10,[20][21][22]25,[37][38][39][40][41][42][43][44]. Particularly unsatisfactory results have been reported in patients with CIED infections despite treatment in accordance with guideline recommendations [1][2][3], with mortality being 20% in the first year, 35% at 3 years and even 40-45% at five years [20,21,25,[41][42][43][44][45].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A considerable number of reports have been published on long-term survival following transvenous lead extraction [10,[20][21][22]25,[37][38][39][40][41][42][43][44]. Particularly unsatisfactory results have been reported in patients with CIED infections despite treatment in accordance with guideline recommendations [1][2][3], with mortality being 20% in the first year, 35% at 3 years and even 40-45% at five years [20,21,25,[41][42][43][44][45].…”
Section: Discussionmentioning
confidence: 99%
“…The main risk factors can be classified into several categories: patient-dependent factors (heart failure, AF, low EF) [20,37,41,45], comorbidity-dependent factors (diabetes, renal failure) [20,38,39,41,42], infection-dependent factors (any infection, systemic infection, valve endocarditis, vegetations, large vegetations, vegetation remnants after TLE, MRSA infection, thrombocytopenia, anaemia) [10,25,[37][38][39][40][41]43,45], CIED-related factors (any CRT infection, lead number, CRT-p infection) [37,[41][42][43] and extraction-related factors (removal of multiple leads, lack of clinical success, major and minor extraction complications, presence of ghosts after TLE, retained lead fragments) [20][21][22]39,[42][43][44].…”
Section: Discussionmentioning
confidence: 99%
“…The strongest indication for TLE is CIED infections [ 6 , 7 ]. CIED infections have become increasingly prevalent, due to the number of CIED implantation procedures and since these procedures are performed in an aging population with multiple comorbidities [ 8 , 9 ]. The multiplication of cardiac pacing centers where staff experience is inadequate can be another explanation [ 10 ].…”
Section: Indications For Lead Extractionmentioning
confidence: 99%
“…According to the most recent European Heart Rhythm Association (EHRA) guidelines [ 5 ], infected lead extraction is always recommended and a percutaneous approach is the first choice (TLE: transvenous lead extraction). Although the high rates of successful percutaneous removal, in-hospital mortality can reach 2.3%, especially when a systemic infection is suspected [ 6 ]. In these settings, as well as in large (>20 mm) vegetations, a vacuum-assisted aspiration of the mass or a conventional surgical approach is suggested [ 5 ].…”
Section: Introductionmentioning
confidence: 99%